+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacovigilance Market Research Report by Type (Contract Outsourcing and In-house), Clinical Trial, Method, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5306611
  • Report
  • April 2022
  • Region: Global
  • 203 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Accenture, PLC
  • ClinChoice Inc.
  • HCL Technologies Limited
  • IQVIA
  • Linical Co., Ltd.
  • Parexel International
The Global Pharmacovigilance Market size was estimated at USD 5,844.39 million in 2020, USD 6,669.16 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.79% to reach USD 13,376.20 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Contract Outsourcing and In-house.
  • Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
  • Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.
  • Based on End User, the market was studied across Academic & Research Institutes, Government Agencies, Health Insurance Companies, Hospitals & Care Providers, and Pharma & Biotech Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmacovigilance Market, including Accenture, PLC, Bristol Myers Squibb, C.H. Boehringer Sohn AG & Ko. KG, Capgemini SE, ClinChoice Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HCL Technologies Limited, ICON PLC, Infosys Limited, International Business Machines Corporation, IQVIA, ITclinical, Laboratory Corporation, Linical Co., Ltd., Novartis International AG, Oracle Corporation, Parexel International, Pfizer Inc., Quanticate International limited, Sanofi S.A., Take Solutions Ltd., Tata Consultancy Services, and Wipro Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmacovigilance Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance Market?
4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance Market?
6. What is the market share of the leading vendors in the Global Pharmacovigilance Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmacovigilance Market?
Frequently Asked Questions about the Global Pharmacovigilance Market

What is the estimated value of the Global Pharmacovigilance Market?

The Global Pharmacovigilance Market was estimated to be valued at $5844.4 Million in 2020.

What is the growth rate of the Global Pharmacovigilance Market?

The growth rate of the Global Pharmacovigilance Market is 14.7%, with an estimated value of $13376.2 Million by 2026.

What is the forecasted size of the Global Pharmacovigilance Market?

The Global Pharmacovigilance Market is estimated to be worth $13376.2 Million by 2026.

Who are the key companies in the Global Pharmacovigilance Market?

Key companies in the Global Pharmacovigilance Market include Accenture, PLC, Bristol Myers Squibb, C.H. Boehringer Sohn AG & Ko. KG, Capgemini SE, ClinChoice Inc., F. Hoffmann, La Roche AG, GlaxoSmithKline PLC and ICON PLC.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accenture, PLC
  • ClinChoice Inc.
  • HCL Technologies Limited
  • IQVIA
  • Linical Co., Ltd.
  • Parexel International

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the Prevalence of Chronic Diseases
5.1.1.2. Rise in Pharmacovigilance Applications in Spontaneous Reporting and Electronic Health Record (EHR) Mining
5.1.1.3. Rise in Demand for Outsourcing Services by Players
5.1.1.4. Rising Incidence of ADR and Drug Toxicity
5.1.2. Restraints
5.1.2.1. High-cost Technology for Small and Mid-sized Players
5.1.3. Opportunities
5.1.3.1. Emergence of COVID-19 have Opened New Opportunities
5.1.3.2. Rising Investment in Research and Development (R&D) by Healthcare Companies
5.1.4. Challenges
5.1.4.1. Lack of Skilled Labor
5.2. Cumulative Impact of COVID-19
6. Pharmacovigilance Market, by Type
6.1. Introduction
6.2. Contract Outsourcing
6.3. In-house
7. Pharmacovigilance Market, by Clinical Trial
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
7.6. Pre-clinical
8. Pharmacovigilance Market, by Method
8.1. Introduction
8.2. Cohort Event Monitoring
8.3. EHR Mining
8.4. Intensified ADR Reporting
8.5. Spontaneous Reporting
8.6. Targeted Spontaneous Reporting
9. Pharmacovigilance Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Government Agencies
9.4. Health Insurance Companies
9.5. Hospitals & Care Providers
9.6. Pharma & Biotech Companies
10. Americas Pharmacovigilance Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmacovigilance Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pharmacovigilance Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Accenture, PLC
14.2. Bristol Myers Squibb
14.3. C.H. Boehringer Sohn AG & Ko. KG
14.4. Capgemini SE
14.5. ClinChoice Inc.
14.6. F. Hoffmann-La Roche AG
14.7. GlaxoSmithKline PLC
14.8. HCL Technologies Limited
14.9. ICON PLC
14.10. Infosys Limited
14.11. International Business Machines Corporation
14.12. IQVIA
14.13. ITclinical
14.14. Laboratory Corporation
14.15. Linical Co., Ltd.
14.16. Novartis International AG
14.17. Oracle Corporation
14.18. Parexel International
14.19. Pfizer Inc.
14.20. Quanticate International limited
14.21. Sanofi S.A.
14.22. Take Solutions Ltd.
14.23. Tata Consultancy Services
14.24. Wipro Limited
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACOVIGILANCE MARKET: DYNAMICS
FIGURE 2. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 3. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2026
FIGURE 5. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2020 VS 2026 (%)
FIGURE 10. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2026
FIGURE 12. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2020 VS 2026 (%)
FIGURE 23. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2026
FIGURE 25. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 36. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2026
FIGURE 38. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. AMERICAS PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. BRAZIL PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. CANADA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. MEXICO PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. CHINA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. INDIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. INDONESIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. JAPAN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. MALAYSIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. PHILIPPINES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. SINGAPORE PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH KOREA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. TAIWAN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. THAILAND PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. FRANCE PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. GERMANY PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. ITALY PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. NETHERLANDS PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. QATAR PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. RUSSIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. SAUDI ARABIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. SOUTH AFRICA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. SPAIN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. GLOBAL PHARMACOVIGILANCE MARKET: FPNV POSITIONING MATRIX
FIGURE 79. GLOBAL PHARMACOVIGILANCE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACOVIGILANCE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACOVIGILANCE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY REGION, 2018-2026 (USD MILLION)
TABLE 42. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY REGION, 2018-2026 (USD MILLION)
TABLE 47. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY STATE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 52. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 53. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 54. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 56. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 57. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 58. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 59. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 62. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 63. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 64. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 66. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 67. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 68. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 69. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 70. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 72. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 73. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 74. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 75. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 77. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 78. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 79. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 80. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 82. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 83. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 84. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 85. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 87. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 88. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 89. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 90. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 92. AMERICAS PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 93. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 94. BRAZIL PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 95. CANADA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 96. MEXICO PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 97. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 98. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 99. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 100. CHINA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 101. INDIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 102. INDONESIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 103. JAPAN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 104. MALAYSIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 105. PHILIPPINES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 106. SINGAPORE PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 107. SOUTH KOREA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 108. TAIWAN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 109. THAILAND PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 111. FRANCE PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 112. GERMANY PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 113. ITALY PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 114. NETHERLANDS PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 115. QATAR PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 116. RUSSIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 117. SAUDI ARABIA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 118. SOUTH AFRICA PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 119. SPAIN PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 121. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 122. GLOBAL PHARMACOVIGILANCE MARKET: SCORES
TABLE 123. GLOBAL PHARMACOVIGILANCE MARKET: BUSINESS STRATEGY
TABLE 124. GLOBAL PHARMACOVIGILANCE MARKET: PRODUCT SATISFACTION
TABLE 125. GLOBAL PHARMACOVIGILANCE MARKET: RANKING
TABLE 126. GLOBAL PHARMACOVIGILANCE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 127. GLOBAL PHARMACOVIGILANCE MARKET: MERGER & ACQUISITION
TABLE 128. GLOBAL PHARMACOVIGILANCE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 129. GLOBAL PHARMACOVIGILANCE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 130. GLOBAL PHARMACOVIGILANCE MARKET: INVESTMENT & FUNDING
TABLE 131. GLOBAL PHARMACOVIGILANCE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 132. GLOBAL PHARMACOVIGILANCE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Accenture, PLC
  • Bristol Myers Squibb
  • C.H. Boehringer Sohn AG & Ko. KG
  • Capgemini SE
  • ClinChoice Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • HCL Technologies Limited
  • ICON PLC
  • Infosys Limited
  • International Business Machines Corporation
  • IQVIA
  • ITclinical
  • Laboratory Corporation
  • Linical Co., Ltd.
  • Novartis International AG
  • Oracle Corporation
  • Parexel International
  • Pfizer Inc.
  • Quanticate International limited
  • Sanofi S.A.
  • Take Solutions Ltd.
  • Tata Consultancy Services
  • Wipro Limited
Note: Product cover images may vary from those shown

Loading
LOADING...